カルナバイオサイエンスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/08/28 | 1,414 | 1,427 | 1,405 | 1,412 | +4 | +0.3% | 43,200 |
| 2017/08/25 | 1,403 | 1,414 | 1,403 | 1,408 | -3 | -0.2% | 27,400 |
| 2017/08/24 | 1,418 | 1,434 | 1,410 | 1,411 | +8 | +0.6% | 48,100 |
| 2017/08/23 | 1,395 | 1,422 | 1,395 | 1,403 | -5 | -0.4% | 29,400 |
| 2017/08/22 | 1,390 | 1,415 | 1,390 | 1,408 | +4 | +0.3% | 34,800 |
| 2017/08/21 | 1,448 | 1,449 | 1,404 | 1,404 | -46 | -3.2% | 59,000 |
| 2017/08/18 | 1,466 | 1,478 | 1,441 | 1,450 | -49 | -3.3% | 84,800 |
| 2017/08/17 | 1,430 | 1,499 | 1,430 | 1,499 | +76 | +5.3% | 92,400 |
| 2017/08/16 | 1,402 | 1,428 | 1,397 | 1,423 | +21 | +1.5% | 59,700 |
| 2017/08/15 | 1,389 | 1,424 | 1,389 | 1,402 | +15 | +1.1% | 82,700 |
| 2017/08/14 | 1,378 | 1,395 | 1,354 | 1,387 | -25 | -1.8% | 91,100 |
| 2017/08/10 | 1,441 | 1,452 | 1,408 | 1,412 | -29 | -2% | 118,800 |
| 2017/08/09 | 1,511 | 1,516 | 1,435 | 1,441 | -67 | -4.4% | 146,500 |
| 2017/08/08 | 1,511 | 1,517 | 1,489 | 1,508 | -29 | -1.9% | 71,400 |
| 2017/08/07 | 1,534 | 1,537 | 1,511 | 1,537 | +32 | +2.1% | 52,300 |
| 2017/08/04 | 1,506 | 1,521 | 1,500 | 1,505 | -17 | -1.1% | 46,300 |
| 2017/08/03 | 1,541 | 1,541 | 1,502 | 1,522 | -9 | -0.6% | 51,900 |
| 2017/08/02 | 1,525 | 1,542 | 1,521 | 1,531 | +6 | +0.4% | 43,400 |
| 2017/08/01 | 1,553 | 1,555 | 1,521 | 1,525 | -34 | -2.2% | 76,700 |
| 2017/07/31 | 1,591 | 1,606 | 1,534 | 1,559 | -48 | -3% | 134,400 |
| 2017/07/28 | 1,642 | 1,642 | 1,600 | 1,607 | -35 | -2.1% | 117,800 |
| 2017/07/27 | 1,650 | 1,658 | 1,638 | 1,642 | -9 | -0.5% | 30,900 |
| 2017/07/26 | 1,650 | 1,660 | 1,637 | 1,651 | ±0 | ±0% | 46,200 |
| 2017/07/25 | 1,649 | 1,661 | 1,642 | 1,651 | +2 | +0.1% | 37,600 |
| 2017/07/24 | 1,653 | 1,664 | 1,645 | 1,649 | -10 | -0.6% | 55,200 |
| 2017/07/21 | 1,670 | 1,681 | 1,654 | 1,659 | -16 | -1% | 47,300 |
| 2017/07/20 | 1,681 | 1,685 | 1,673 | 1,675 | ±0 | ±0% | 29,600 |
| 2017/07/19 | 1,660 | 1,679 | 1,652 | 1,675 | +13 | +0.8% | 33,200 |
| 2017/07/18 | 1,660 | 1,669 | 1,650 | 1,662 | -8 | -0.5% | 60,400 |
| 2017/07/14 | 1,666 | 1,679 | 1,659 | 1,670 | -2 | -0.1% | 41,600 |
| 2017/07/13 | 1,685 | 1,685 | 1,656 | 1,672 | +2 | +0.1% | 45,100 |
| 2017/07/12 | 1,673 | 1,695 | 1,663 | 1,670 | -9 | -0.5% | 62,300 |
| 2017/07/11 | 1,682 | 1,702 | 1,669 | 1,679 | -14 | -0.8% | 86,400 |
| 2017/07/10 | 1,681 | 1,703 | 1,675 | 1,693 | +18 | +1.1% | 46,900 |
| 2017/07/07 | 1,665 | 1,682 | 1,661 | 1,675 | +6 | +0.4% | 48,100 |
| 2017/07/06 | 1,672 | 1,691 | 1,662 | 1,669 | -8 | -0.5% | 58,400 |
| 2017/07/05 | 1,685 | 1,703 | 1,666 | 1,677 | -2 | -0.1% | 65,400 |
| 2017/07/04 | 1,758 | 1,760 | 1,666 | 1,679 | -85 | -4.8% | 143,100 |
| 2017/07/03 | 1,738 | 1,789 | 1,737 | 1,764 | +24 | +1.4% | 136,200 |
| 2017/06/30 | 1,668 | 1,749 | 1,665 | 1,740 | +52 | +3.1% | 137,900 |
| 2017/06/29 | 1,655 | 1,690 | 1,653 | 1,688 | +31 | +1.9% | 70,500 |
| 2017/06/28 | 1,683 | 1,683 | 1,652 | 1,657 | -29 | -1.7% | 68,300 |
| 2017/06/27 | 1,655 | 1,696 | 1,642 | 1,686 | +27 | +1.6% | 91,200 |
| 2017/06/26 | 1,691 | 1,693 | 1,630 | 1,659 | -6 | -0.4% | 220,300 |
| 2017/06/23 | 1,697 | 1,702 | 1,646 | 1,665 | -65 | -3.8% | 295,400 |
| 2017/06/22 | 1,702 | 1,735 | 1,700 | 1,730 | +28 | +1.6% | 102,200 |
| 2017/06/21 | 1,700 | 1,704 | 1,660 | 1,702 | +2 | +0.1% | 125,700 |
| 2017/06/20 | 1,720 | 1,720 | 1,699 | 1,700 | -17 | -1% | 115,000 |
| 2017/06/19 | 1,700 | 1,733 | 1,700 | 1,717 | +7 | +0.4% | 85,200 |
| 2017/06/16 | 1,715 | 1,723 | 1,691 | 1,710 | +3 | +0.2% | 82,600 |
1951～
2000
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カルナバイオ | 22,700円 | +13.5% | - | 0.00% | - | 3.12倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| リボミック | 10,200円 | -100.0% | - | 0.00% | - | 1.49倍 |
|
東大発の創薬ベンチャー。ＲＮＡ（リボ核酸）を利用した分子標的薬（アプタマー医薬）を開発 |
| 免疫生物 | 48,000円 | +5.8% | +14.8% | 1.25% | 16.88倍 | 2.95倍 |
|
体外診断薬や研究用抗体製販・受託。遺伝子組み換えカイコは細胞培養足場材や化粧品展開 |
| クリングル | 48,500円 | -11.3% | - | 0.00% | - | 2.09倍 |
|
阪大発創薬ベンチャー。細胞増殖等機能持つＨＧＦタンパク利用した難治性疾患治療薬を開発 |
| 窪田製薬 | 5,000円 | +640.7% | - | 0.00% | - | 2.81倍 |
|
眼科医薬ベンチャー。近視矯正「クボタメガネ」の開発に注力、眼疾患治療薬の開発は中断状態 |
市場注目の銘柄
チャート関連のコラム
